|
Eurand Stage: Spin-outs Date of Investment: 1999 Web Site : http://www.eurand.com Stock Symbol : Nasdaq: EURX |
 |
Headquartered in Milan, Italy, Eurand is a leading international oral drug-delivery company with integrated research, development and production facilities in Europe and North America. Warburg Pincus acquired the company from American Home Products, Inc. in 1999 (Wyeth). Eurand's drug-delivery technologies are used to enhance the performance and extend the patent life of existing drugs by improving solubility, decreasing the number of doses required per day, improving the efficacy/side effect profile and masking their unpleasant taste. Eurand is leveraging its portfolio of existing and new technologies to develop a broad portfolio of partnered and self developed research and development projects. The company completed an initial public offering in May 2007 (Nasdaq: EURX).
